Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Erlangen University Medical School selects BSD MR-Hybrid Hyperthermia system

BSD Medical : 24 January, 2008  (New Product)
The Erlangen University Medical School in Erlangen, Germany has installed BSD Medical’s BSD-2000/3D/MR Hybrid Hyperthermia System to become the third site for a MR Hybrid Hyperthermia System in Germany.
The system was selected following research results in MR-Hybrid Hyperthermia that took place at the Charite University Medical School in Berlin.

The research was made possible by a special research grant from the German Federal Research Council (DFG Deutsche Forschungsgemeinschaft), as well as at the Grosshadern Campus of the Munich University Medical School (promoted by the German Cancer Aid Foundation (Stiftung Deutsch Krebshilfe).

Hyperthermia is the most effective modality for sensitisation of malignant tumours for radiation. The Erlangen Department of Radiation Oncology has been engaged with the application of microwave based clinical hyperthermia for many years. Advanced cervical cancer, locally recurring rectal cancer, recurrent breast cancer, bladder cancer, soft tissue sarcoma and malignant melanoma are all treated by adjuvant hyperthermia in the frame of national and international (investigational) treatment protocols.

Other tumour entities are under consideration to be addressed. A hybrid system provides non-invasive access to treatment parameters such as thermal dose, tumour and tissue perfusion in the form of specially coded MR images. This allows experimental access to a vast field of innovative clinical applications and experimental research.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo